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We determined whether cutaneous angiogenesis induced
by exposure of mice to ultraviolet-B (UVB) radiation
is associated with an imbalance between positive and
negative angiogenesis-regulating molecules. Unshaved
C3H/HeN mice were exposed to a single dose (15 kJ per
m2) of UVB. At various times, the mice were killed, and
their external ears were processed for routine histology
and immunohistochemistry. Antibodies against proli-
ferating cell nuclear antigen and bromodeoxyuridine
identified dividing cells. Antibodies against CD31/
PECAM-1 identified endothelial cells, and antibodies
against basic fibroblast growth factor (bFGF), vascular
endothelial growth factor/vascular permeability factor,
and interferon-b (IFN-b) identified angiogenesis-regulat-
ing molecules. Epidermal hyperplasia was documented
by 48 h and reached a maximum on day 7 after exposure
The formation of blood vessels, i.e., angiogenesis, isessential for normal reproduction, development, woundhealing and repair, and tumor growth (Folkman, 1995).To form a new blood vessel, endothelial cells mustdegrade the basement membrane of existing vessels,
invade through the walls of the venules, migrate toward an angiogenic
stimulus, proliferate as they align in a linear fashion to form sprouts,
and differentiate to form tubes through which blood will ultimately
flow (Folkman, 1995). Factors that stimulate angiogenesis include
members of the fibroblast growth factor family, vascular endothelial
growth factor/vascular permeability factor (VEGF/VPF), platelet
derived endothelial cell growth factor, interleukin-8 (IL-8), platelet-
derived growth factor, and matrix metalloproteinases (Folkman and
Klagsbrun, 1987; Auerbach and Auerbach, 1994; Fidler and Ellis, 1994;
Singh et al, 1995b). Negative regulators of angiogenesis include
interferons, thrombospondin, platelet factor 4, prolactin fragment,
angiostatin, endostatin, and tissue inhibitors of metalloproteinases
(Auerbach and Auerbach, 1994; Fidler and Ellis, 1994; O’Reilly et al,
1994, 1997; Singh et al, 1995a). The extent of angiogenesis is determined
by the balance between positive and negative endogenous molecules.
Pathologic conditions such as psoriasis, retinopathy, and vascular
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to UVB. The expression of bFGF increased by 24 h,
whereas the expression of IFN-b decreased by 72 h after
exposure to UVB. The expression of vascular endothelial
growth factor/vascular permeability factor increased
slightly after irradiation. The altered balance between
bFGF and IFN-b was associated with increased endothel-
ial cell proliferation (bromodeoxyuridineF CD31F cells)
within existing blood vessels, leading to telangiectasia
and new blood vessels. UV-induced epidermal hyperplasia
and cutaneous angiogenesis were highest in IFN-a/b
receptor knockout mice. These results demonstrate that
in response to UVB radiation, dividing keratinocytes
produce a positive angiogenic molecule (bFGF) but not
a negative angiogenic molecule (IFN-b), and that this
altered balance is associated with enhanced cutaneous
angiogenesis. Key words: bFGF/IFN-b/UVB radiation. J
Invest Dermatol 111:864–872, 1998
neoplasms, e.g., hemangioma and angiofibroma, are associated with an
imbalance between angiogenesis-regulating molecules (Folkman, 1995).
Cutaneous infantile hemangiomas represent a relatively pure form
of pathologic angiogenesis. These benign tumors are characterized by
rapid proliferation of capillaries in the first year of life (proliferative
phase), slow growth during the next 5 y (involuting phase), and
eventual involution or complete regression by 10–15 y of age (involuted
phase) (Ezekowitz et al, 1992). In a previous study, we examined the
hypothesis that the progression and involution of hemangiomas are
associated with the relative levels of expression of positive and negative
angiogenic molecules. We found that proliferating and involuting
tumors expressed high levels of basic fibroblast growth factor (bFGF)
and VEGF/VPF but not interferon-β (IFN-β) (mRNA or protein).
Moreover, the epidermis directly overlying proliferating and early
involuting hemangiomas was hyperplastic and expressed high levels of
bFGF and VEGF/VPF but not IFN-β. In contrast, the epidermis from
age-matched normal individuals, the epidermis directly overlying
involuted lesions, and the epidermis at sites distant from proliferating
hemangiomas, were not hyperplastic and expressed IFN-β as well
as bFGF and VEGF/VPF. These findings suggest that epidermal
hyperplasia surrounding proliferating hemangioma produces bFGF and
VEGF/VPF but not IFN-β, and thus contributes to the angiogenesis
of the neoplasms.1
To further examine the relationship between epidermal hyperplasia
and cutaneous angiogenesis, we studied the well-documented effects
of ultraviolet (UV) radiation on the skin. Exposure to UV radiation,
1Bielenberg, DR, Bucana CD, Mulliken J, Folkman J, Fidler IJ: Loss of an
endogenous negative angiogenic factor in the epidermis overlying hemangioma
lesions. Proc Am Assoc Cancer Res 38:524, 1997 (abstr.)
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Figure 1. Induction of epidermal hyperplasia and cutaneous angiogenesis by UVB radiation. C3H/HeN mice were exposed to a single 15 kJ per m2
dose of UVB and killed 1, 2, 3, 5, or 7 d after irradiation. Their ears were resected and either formalin-fixed and paraffin-embedded for histologic (hematoxylin
and eosin stain) and for immunohistochemical staining with antibodies to PCNA, or frozen in OCT compound for immunohistochemical staining with antibodies
to CD31/PECAM-1. Age-matched, unirradiated mice served as controls. Note increased thickening of the epidermis and increased numbers of PCNA1 cells
(brown) after UV exposure. CD31/PECAM-1 staining (pink) reveals an increase in the size and number of blood vessels after UV irradiation. Scale bar: 50 µm.
especially UVB radiation (280–320 nm), causes sunburn, immuno-
suppression, and ultimately skin cancer (Kripke, 1994). A single
exposure to UVB radiation can induce erythema (Cox et al, 1992;
Kripke, 1994; Naylor, 1997), epidermal hyperplasia, and increased
cutaneous vascularization (Soffen and Blum, 1961; Pearse et al, 1987;
Donawho et al, 1994; Berton et al, 1997). Subsequent to exposure to
UVB radiation, keratinocytes produce a plethora of proinflammatory
cytokines such as IL-1 (Schwarz and Luger, 1989; Kripke, 1994), IL-3
(Schwarz and Luger, 1989), IL-6 (Schwarz and Luger, 1989; Chung
et al, 1996), tumor necrosis factor-α (Schwarz and Luger, 1989; Rivas
and Ullrich, 1994; Strickland et al, 1997), granulocyte-macrophage
colony-stimulating factor (Schwarz and Luger, 1989), and IL-12 (Enk
et al, 1996); immunosuppressive cytokines such as IL-4 and IL-10
(Rivas and Ullrich, 1994); and angiogenic molecules such as bFGF
(Kramer et al, 1993), VEGF/VPF (Brauchle et al, 1996), IL-8 (Kondo
et al, 1993; Singh et al, 1995b; Strickland et al, 1997), and matrix
metalloproteinases (Singh et al, 1995b).
We examined whether cutaneous angiogenesis induced by exposure
of mice to UVB radiation is associated with an imbalance between
positive and negative angiogenic molecules. We show that a single
exposure to UVB radiation (15 kJ per m2) produces first an increase
in expression of bFGF and then a decrease in expression of IFN-β
in association with epidermal hyperplasia and angiogenesis in the
underlying tissues.
MATERIALS AND METHODS
Animals Specific pathogen-free, female C3H/HeN (MTV-) mice were
purchased from the Animal Production Area of the National Cancer Institute-
Frederick Cancer Research Facility (Frederick, MD) and used when they were
8–12 wk of age. Breeding pairs of A129 mice lacking the receptor for type I
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Figure 2. Expression of positive and negative angiogenic molecules. C3H/HeN mice were exposed to a single 15 kJ per m2 dose of UVB and killed at
various times following irradiation (days 1, 2, 3, 5, and 7). The ears were resected and either formalin-fixed and paraffin-embedded for IHC with antibodies to
VEGF/VPF, or frozen in OCT for IHC with antibodies to bFGF and IFN-β. Age-matched, unirradiated mice served as controls. Mean OD of each sample’s
staining intensity in the epidermis is noted in the top right corner. Epidermis from unirradiated-control mice expressed VEGF/VPF and IFN-β, but did not express
detectable bFGF. By day 1 following UVB radiation, the level of bFGF in the epidermis increased dramatically. VEGF/VPF expression increased slightly. IFN-β
expression intensity decreased gradually during days 1–5 as epithelial and endothelial cell proliferation increased. Scale bar: 50 µm.
interferon (Huang et al, 1993; Mu¨ller et al, 1994) were purchased from B&K
Universal (Hull, U.K.). Female A129 mice were used at 10 wk of age. Age-
matched female 129SVEV (wild-type interferon receptor) mice were purchased
from Taconic (Germantown, NY). The mice were maintained in facilities
approved by the American Association for Accreditation of Laboratory Animal
Care and in accordance with current United States Department of Agriculture,
Department of Health and Human Services, and National Institutes of Health
regulations and standards and with institutional guidelines. All procedures were
approved by the Institutional Animal Care and Use Committee.
UV irradiation Unshaved mice were exposed to a single 15 kJ per m2 dose
of UVB radiation (7.5 times the minimal erythemal dose) supplied by a bank
of six Westinghouse FS40 sunlamps (National Biological, Twinsburg, OH) that
deliver µ65% of their total energy in the UVB (280–340 nm) wavelength
range (Donawho and Kripke, 1991; Donawho et al, 1994). During irradiation,
the mice were housed five per cage but were separated by clear plastic partitions
on a shelf 20 cm below the fluorescent bulbs. The mice were killed at various
times and their exposed external ears were resected and processed for histologic
and immunohistochemical evaluation. Age-matched, unirradiated mice served
as controls. Specimens either were fixed in 10% buffered formalin and embedded
in paraffin or were embedded in OCT compound (Miles, Elkhart, IN), rapidly
frozen in liquid nitrogen, and stored at –70°C.
Antibodies Rabbit anti-mouse IFN-β antibody was purchased from Access
Biomedical (San Diego, CA). Rabbit anti-bFGF antibody was purchased from
Sigma (St. Louis, MO). Rabbit anti-VEGF/VPF antibody was purchased
from Santa Cruz (Santa Cruz, CA). Monoclonal mouse anti-proliferating cell
nuclear antigen (PCNA) (clone PC10) antibody was purchased from Dako
(Carpinteria, CA). Peroxidase-conjugated rat anti-mouse IgG2a was
purchased from Serotec (Harlan Bioproducts for Science, Indianapolis, IN).
Rat anti-mouse CD31/PECAM-1 antibody and peroxidase-conjugated rat anti-
mouse IgG1 were purchased from Pharmingen (San Diego, CA). Monoclonal
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Figure 3. Regression of epidermal hyperplasia and cutaneous angiogenesis. C3H/HeN mice were exposed to a single 15 kJ per m2 dose of UVB and
killed 1, 2, 3, 4, or 7 wk following irradiation. Their ears were resected and frozen in OCT for immunohistochemical staining with antibodies to bFGF, IFN-β,
and CD31/PECAM-1. bFGF expression remained elevated for 3–4 wk compared with unirradiated controls (see Fig 2) following a single exposure to UVB.
IFN-β expression began to increase 3–4 wk after UV exposure. This increase was followed by a decrease in the number of dermal blood vessels. The mean OD
of each sample’s staining intensity in the epidermis is noted in the top right corner. Scale bar: 50 µm.
mouse anti-bromodeoxyuridine (BrdU) IgG1 clone B44 was purchased from
Becton Dickinson (San Jose, CA). Peroxidase-conjugated goat anti-rabbit IgG
F(ab9)2 and peroxidase-conjugated goat anti-rat IgG (H 1 L) were purchased
from Jackson Research Laboratories (West Grove, PA). Alkaline phosphatase-
conjugated mouse anti-rat IgG (H 1 L) was purchased from Boehringer
(Indianapolis, IN).
Immunohistochemistry Formalin-fixed paraffin-embedded tissues were
used for routine histology and immunohistochemistry to identify dividing cells
(PCNA) and VEGF/VPF. The tissues were sectioned at 4–6 µm thickness,
mounted on positively charged Superfrost slides (Fisher Scientific, Houston,
TX), and allowed to dry overnight at room temperature. Sections were
deparaffinized in xylene followed by a graded series of alcohols (100%, 95%,
and 80% ethanol) and rehydrated in phosphate-buffered saline (PBS; pH 7.5).
Sections analyzed for PCNA were microwaved for 5 min for ‘‘antigen retrieval’’
(Shi et al, 1991). All other paraffin-embedded tissue sections were treated with
pepsin (Biomeda, Foster City, CA) for 15 min at 37°C and then washed three
times for 3 min each time with PBS.
Frozen tissues were used for identification of bFGF, CD31/PECAM-1, IFN-
β, and BrdU. Frozen tissues were sectioned (8–10 µm), mounted on positively
charged Plus slides (Fisher Scientific), and air-dried for 30 min. Frozen tissues
were then fixed in cold acetone (5 min), acetone/chloroform 1:1 (5 min), and
acetone (5 min) and washed with PBS three times for 3 min each time.
After pepsin treatment (paraffin-embedded tissues) or fixation (frozen tissues),
all samples were incubated with 3% H2O2 in methanol solution for 12 min at
room temperature to block endogenous peroxidases. Sections were washed
three times with PBS and then incubated for 20 min at room temperature in
a protein blocking solution consisting of PBS supplemented with 1% bovine
serum albumin, 1% normal goat serum, and 5% normal horse serum. The
primary antibodies were diluted in protein blocking solution to the desired
concentration and applied to the sections overnight at 4°C. The sections were
rinsed three times in PBS, incubated for 10 min in protein blocking solution,
incubated with secondary antibody for 1 h at room temperature, and washed.
Samples exposed to peroxidase-conjugated antibodies were then incubated with
stable diaminobenzidine (Research Genetics, Huntsville, AL), and those exposed
to alkaline phosphatase-conjugated antibodies were incubated with fast red
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Table I. Quantitation of epidermal thickness, proliferative
index, and MVD during the progression of hyperplasia and
angiogenesis following UVB irradiation in C3H/HeN micea
Epidermal Proliferative
Days thickness (µm) index (%) MVD
NR 11.7 6 2.6 12.7 6 4.0 5.2 6 1.5
1 15.9 6 3.8 20.3 6 5.2 6.5 6 1.9
2 27.0 6 6.9b 27.0 6 6.4 6.8 6 1.9
3 48.2 6 12b 29.3 6 4.4c 5.7 6 1.3
5 53.7 6 8.8b 55.0 6 6.4c 7.8 6 1.1c
7 68.9 6 10.9b 60.5 6 11.5c 9.9 6 2.6c
aThe values are mean 6 SD. NR, unirradiated (control) tissue. The proliferative index
was calculated as the number of PCNA1 epidermal cells/the total number of epidermal
cells within 20 2003 fields on the dorsal side of the ear. MVD was calculated as the mean
number of blood vessels (CD31/PECAM-11) in a 20,000 µm2 area of the dermis on the
dorsal side of the ear.
bp , 0.001 by the Kruskal–Wallis nonparametric analysis of variance test in comparison
with control tissue.
cp , 0.001 by the Student’s t test in comparison with control tissue.
chromogenic substrate (Biomeda, Foster City, CA). Staining was monitored
under a bright field microscope, and the reaction was stopped by washing
with distilled water. Sections were counterstained with Gill’s 3 hematoxylin
(Sigma) and mounted with Universal Mount (Research Genetics). The con-
centrations of primary and secondary antibodies were predetermined using
separate specimens that were included in the assay as controls. Control specimens
exposed to secondary antibody alone showed no specific staining. The intensity
of the cytoplasm staining was quantitated using Optimas Image Analysis software
(Bioscan). Optical density (OD) was defined as the integrated log of the inverse
gray value. OD was measured in the epidermis of control and UV irradiated
ears after bFGF, VEGF/VPF, and IFN-β immunohistochemical staining.
Identification of dividing endothelial cells To identify dividing cells
in vivo, mice were injected twice intravenously with 0.2 ml saline containing
250 µg BrdU (Sigma) 4 h and 1 h before they were euthanized (Fujimaki et al,
1993). The mice’s ears were resected and embedded as described above.
Immunohistochemical staining was performed on the frozen tissues as described
above with rat anti-mouse CD31/PECAM-1 antibody, peroxidase-conjugated
goat anti-rat IgG, and diaminobenzidine chromogen (brown precipitate). The
sections were then washed with PBS three times for 3 min each time, treated
with 1% Triton X-100 in PBS for 8 min, and rinsed again with PBS three
times for 3 min each time. Samples were incubated with 2N HCl in PBS at
37°C for 30 min. Sections were next rinsed with PBS three times for 3 min
each time, treated with protein blocking solution and primary monoclonal
mouse anti-BrdU antibody overnight at 4°C, and then treated with protein
blocking solution and secondary rat anti-mouse IgG1 for 1 h. The sections
were then incubated in a second chromogen, 3-amino-9-ethylcarbazole (red
precipitate) (BioGenex, San Ramon, CA) for 5–20 min and mounted as
described above. Dividing endothelial cells exhibited red nuclei and brown
cytoplasm.
Epidermal thickness and proliferative index Sections of formalin-fixed,
paraffin-embedded ears were stained with hematoxylin and eosin stain or with
antibodies to PCNA. Images of five fields at 2003 magnification were captured
for each ear using a Sony 3-chip camera (Sony, Montvale, NJ), mounted on a
Zeiss universal microscope (Carl Zeiss, Thornwood, NY), and Optimas Image
Analysis software (Bioscan, Bothell, WA) installed in a PC computer with a
Pentium chip, a frame grabber, an optical disk storage system, and a Sony color
printer. To minimize changes in background and color intensities, all images
to be used for analysis were digitized and stored for further analysis. Epidermal
thickness was determined from an average of 100 separate measurements (10
thickness measurements along each of five 200 µm lengths of tissue from each
of two different mouse ears). The significance of differences in epidermal
thickness was calculated using the Kruskal–Wallis nonparametric analysis of
variance test with Dunn’s multiple comparisons test (InSTAT 2.0 software).
The proliferative index, expressed as a percentage, was calculated as the number
of proliferating cells (PCNA1)/the total number of epidermal cells in 20 2003
fields. The thickness and proliferative index were measured in the dorsal
epidermis of the ear. The significance of differences in PCNA1 cells/field and
proliferative index was calculated using the Student’s t test (two-tailed). All
values are reported as means 6 SD.
Quantitation of microvessel density (MVD) Control and UVB-exposed
ears were embedded in OCT compound and frozen, sectioned, fixed, and
stained with antibodies to CD31/PECAM-1 (Veechi et al, 1994). Images of
10 1003 fields per ear were digitized and stored for further analysis. The
number of blood vessels was counted in each field in the dermis on the dorsal
(UVB-exposed) side of the ears. The total area of dermis in each field was
determined with the Optimas software program. MVD was calculated as the
mean number of blood vessels (CD31/PECAM-11 cells) in a 20,000 µm2 area
of dermis. The significance of differences was calculated using the Student’s t
test (two-tailed).
RESULTS
Induction of epidermal hyperplasia by UVB radiation In the
first set of experiments, unshaved C3H/HeN mice were exposed to a
single 15 kJ per m2 dose of UVB radiation. The mice were killed after
various intervals, and their external ears were processed for histologic
and immunohistochemical evaluation. Hematoxylin and eosin staining
revealed that epidermal hyperplasia began by 48 h after UVB exposure
and peaked on day 7 (Figs 1, 2) and began to decline by 2 wk after
exposure (Fig 3). The mean thickness of the epidermis progressively
increased from 11.7 6 2.6 µm to 68.9 6 10.9 µm (Table I) and was
accompanied by an apparent thickening of the dermis (Figs 1–3). The
UVB-induced epidermal hyperplasia was local because ventral skin
thickness was unchanged (data not shown).
UVB radiation induces proliferation of keratinocytes Immuno-
histochemical analysis using antibodies against PCNA, a protein
expressed during the S phase of the cell cycle (Coltrera and Gown,
1991; Wolf and Dittrich, 1992), revealed that the normal (unirradiated)
epidermis contained few PCNA1 keratinocytes in the basal cell layer
(Fig 1). By 24 and 48 h after UVB irradiation, an increased number
of PCNA1 keratinocytes were found in the basal layer. The number
of PCNA1 cells continued to increase, and by day 3 the cells were
dispersed throughout the epidermis. The mean number of PCNA1
cells per field in the epidermis increased gradually from 7.2 6 1.3
(12.7%), and by day 7 after UVB exposure it reached 124.4 6 31
(60.5%) (Fig 1, Table I).
UVB radiation induces endothelial cell proliferation Immuno-
staining with antibodies against CD31/PECAM-1 identifies endothelial
cells in murine tissues (Veechi et al, 1994). In our study, UVB irradiation
first induced dilatation of blood vessels (telangiectasia) and then induced
a 2-fold increase in the number of blood vessels per area, i.e., their density
(Figs 1, 4, Table I). These data indicate that the increase in the size of
the skin (overlying the dorsal surface of the ear) was accompanied by an
increase in vasculature, i.e., angiogenesis.
To determine whether UVB induced division of vascular endothelial
cells, normal and UVB-irradiated mice were injected intravenously
twice with BrdU 4 h and 1 h before they were killed. Their ears were
then processed for immunohistochemical staining with antibodies
against CD31/PECAM-1 and BrdU, an analog of thymidine, which
is incorporated into cells entering the S phase of the cell cycle (Coltrera
and Gown, 1991). By day 5 after exposure to UVB radiation,
endothelial cells were dividing. Some of the dividing endothelial cells
were in large vessels, suggesting a mechanism for the observed
telangiectasia. Other dividing endothelial cells appeared to contribute
to new vessel sprouts (Fig 4). Nonirradiated (control) ears and ears
exposed to UVB radiation 3 d earlier did not contain BrdU1
endothelial cells (data not shown).
Cutaneous angiogenesis is associated with an imbalance between
positive and negative angiogenic molecules To determine
whether cutaneous angiogenesis was associated with an imbalance in
the level of expression of angiogenic molecules by the hyperplastic
epithelium, ear sections were studied by immunohistochemical staining
for bFGF, VEGF/VPF, and IFN-β. In quiescent (normal) tissues, the
expression of negative regulators of angiogenesis is usually higher than
that of positive molecules (Fidler and Ellis, 1994; Iruela-Arispe and
Dvorak, 1997). Indeed, the normal (nonirradiated) epidermis showed
stronger staining for IFN-β than for VEGF/VPF or bFGF (Fig 2);
however, within 1 d after exposure of mice to 15 kJ per m2 of UVB
radiation, the expression of bFGF increased and remained elevated for
several weeks (Figs 2, 3). The increase in bFGF expression preceded
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Figure 4. Neovascularization following UVB irradiation. C3H/HeN mice were exposed to a single 15 kJ per m2 dose of UVB. Mice were injected twice
with BrdU 4 h and 1 h prior to euthanasia. The external ears were resected and frozen in OCT for immunohistochemical staining with antibodies against CD31/
PECAM-1 and BrdU. Age-matched, unirradiated mice served as controls. Double labeling reveals that CD31/PECAM-11 endothelial cells (brown) incorporated
BrdU (red) into their DNA. Arrows indicate dividing endothelial cells in the dermis, and arrowheads indicate dividing keratinocytes in the epidermis. Panels represent
tissues from days 5 and 7 after UV exposure. No dividing endothelial cells were found in the nonirradiated skin or skin from mice irradiated 1–3 d before the
assay. Scale bar: 30 µm.
Table II. Quantitation of epidermal thickness and MVD following UVB irradiation in 129SVEV and A129 micea
Epidermal thickness (µm) MVD
Days post-UV IFN-α/βR1/1 IFN-α/βR2/2 IFN-α/βR1/1 IFN-α/βR2/2
NR 9.6 6 2.4 17.9 6 4.5 3.7 6 0.6 4.7 6 0.5
1 13.5 6 3.8 21.5 6 10.11 4.2 6 1.4 4.4 6 1.2
3 40.3 6 19.4b 49.6 6 32.5 5.4 6 1.7 5.0 6 0.7
5 76.2 6 26.8b 75.8 6 32.8b 5.7 6 1.4 4.7 6 0.9
7 89.3 6 26.4b 104.2 6 37.5b 7.5 6 0.9b 6.0 6 1.9
10 67.4 6 22.2b 88.5 6 31.7b 5.6 6 1.4 8.0 6 1.1c
15 56.3 6 11.5b 102.1 6 26.5b 6.1 6 1.1c 6.3 6 0.9c
18 30.7 6 7.6b 134.4 6 36.4b 6.4 6 1.0c 8.0 6 1.6c
21 18.1 6 4.6 143.8 6 27.5b 6.2 6 1.5c 8.8 6 0.8c
28 16.1 6 5.2 104.1 6 22.7b 3.8 6 0.6 6.9 6 1.1c
aThe values are mean 6 SD. NR, unirradiated (control) tissue. Epidermal thickness was determined from an average of 100 separate measurements on the dorsal side of the ear per
time point. MVD was calculated as the mean number of blood vessels (CD31/PECAM-11) in a 20,000 µm2 area of the dermis on the dorsal side of the ear.
bp , 0.001 by the Kruskal–Wallis nonparametric analysis of variance test in comparison with control tissue.
cp , 0.01 by the Student’s t test in comparison with control tissue.
epidermal hyperplasia and the decrease in expression of IFN-β, which
occurred by days 2–3 after UVB irradiation. The intensity of VEGF/
VPF staining in the epidermis and dermis increased slightly after
irradiation.
Kinetics of epidermal hyperplasia and cutaneous angio-
genesis The epidermal hyperplasia and cutaneous angiogenesis that
occurred after a single dose of UVB radiation (15 kJ per m2) were
long lasting. We base this conclusion on the data shown in Fig 3.
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Figure 5. Induction of epidermal hyperplasia and cutaneous angiogenesis by UVB radiation in IFN-a/bR–/– and IFN-a/bR wild-type mice. Mice
were exposed to a single 15 kJ per m2 dose of UVB and killed at various times following irradiation. Their ears were resected and either formalin-fixed and
paraffin-embedded for hematoxylin and eosin staining or frozen in OCT compound for immunohistochemical staining with antibodies to CD31/PECAM-1. Note
that both types of mice had epidermal hyperplasia and increased MVD after 7 d. By day 28, the epidermal hyperplasia reverted to normal in the wild-type mice,
whereas it remained prominent in the IFN-α/βR knockout mice. Scale bar: 50 µm.
Epidermal hyperplasia and angiogenesis reached a maximum by day 7
after UVB irradiation and remained elevated for at least 4 wk. By
week 7, the epidermis thickness, MVD, and expression of IFN-β
equalled those observed in untreated control mice (Figs 1–3). During
this regression, bFGF expression remained elevated as compared with
expression in control mice (Fig 3).
Induction of epidermal hyperplasia and cutaneous angiogenesis
in IFN-a/bR–/– and IFN-a/bR1/1 mice In the last set of
experiments, unshaven A129 and 129SVEV mice were exposed to a
single 15 kJ per m2 dose of UVB radiation. The mice were killed after
various intervals, and their external ears were processed for histologic
and immunohistochemical evaluation. Hematoxylin and eosin staining
revealed that the epidermis of IFN-α/βR1/1 mice became hyperplas-
tic by day 3 following UVB exposure. The epidermal hyperplasia
peaked by day 7 and, similar to C3H/HeN mice, progressively declined
(Table II and Fig 5). The epidermis of IFN-α/βR–/– mice also
became hyperplastic following UVB irradiation, but the hyperplasia
did not decline. The epidermal thickness of IFN-α/βR–/– mice was
twice that of the wild-type mice by 15 d after a single dose of UVB,
four times thicker by 18 d, and nearly eight times thicker by 21 d
(Table II). UVB irradiation induced a 2-fold increase in MVD in
129SVEV mice by 7 d and declined to normal levels by 28 d. In
contrast, MVD peaked at 21 d in IFN-α/βR–/– mice and did not
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decline to normal levels during the time period of this study (Table II).
In addition, dilatation or telangiectasia of blood vessels was still obvious
in A129 mice by 28 d after irradiation (Fig 5).
DISCUSSION
These results indicate that the induction of epidermal hyperplasia
followed by increased cutaneous angiogenesis is associated with an
increase in expression of a positive angiogenic molecule (bFGF) and a
decrease in expression of a negative angiogenic molecule (IFN-β).
Angiogenesis is induced by a change in the balance between positive
and negative regulators (Hanahan et al, 1996). In normal, quiescent
tissues, the negative regulator is usually dominant (Fidler and Ellis,
1994; Iruela-Arispe and Dvorak, 1997). Indeed, in our study the
normal skin (nonirradiated C3H/HeN mice) expressed low levels of
bFGF, low levels of VEGF/VPF, and high levels of IFN-β (in
differentiated keratinocytes and fibroblasts). Shortly after UVB expo-
sure, the expression of bFGF increased and keratinocytes began to
divide. The dividing keratinocytes, like many other dividing cells,
produced bFGF and VEGF/VPF but not IFN-β.1–3 As the epithelial
cell proliferation continued, the balance between positive and negative
angiogenesis-regulating molecules shifted toward an angiogenic pheno-
type, and endothelial cells began to divide, to enlarge existing vessels,
and then to form new sprouts. Epidermal hyperplasia and angiogenesis
reached maximal levels by 7 d after UVB exposure. Epithelial cell
division then ceased, and several weeks later the expression of IFN-β
returned, blood vessels regressed, and epidermal thickness decreased.
The balance of angiogenic molecules was thus shifted back toward
homeostatic levels.
Our data agree with previous reports that the increased expression
of endogenous positive angiogenic factors in the organ environment
is a consequence of tissue damage (Marks and Fu¨rstenberger, 1993;
Brauchle et al, 1996). Indeed, upregulation of VEGF/VPF, bFGF, and
IL-8 has been previously reported to occur subsequent to UVB
irradiation (Kondo et al, 1993; Kramer et al, 1993; Singh et al, 1995b;
Brauchle et al, 1996; Strickland et al, 1997). The finding that increased
expression of bFGF in keratinocytes after UVB exposure is an early
event is new. IFN-β, which is produced by nondividing cells, has been
shown to downregulate transcription and production of bFGF protein
(Singh et al, 1995a; Dinney et al, 1998) and collagenase type IV (Fabra
et al, 1992; Gohji et al, 1994; Kato et al, 1995). In this study, the
decreased expression of IFN-β in the epidermis coincided with
epidermal hyperplasia and induction of angiogenesis. The finding that
UVB radiation induces epidermal hyperplasia in IFN-α/βR–/– mice
that did not revert to normal even after 28 d, supports the conclusion
that epidermal hyperplasia and cutaneous angiogenesis is associated
with the loss of IFN-β (protein or function), an endogenous inhibitor
of angiogenesis.
IFN-β was originally discovered through its anti-viral activity
(Isaacs and Lindenmann, 1957). IFN-β, however, can also inhibit
proliferation of tumor cells, epithelial cells, and endothelial cells, to
name a few (Pfeffer et al, 1998). In addition, IFN-β can inhibit
angiogenesis by several mechanisms, including inhibition of endothelial
cell migration (Brouty-Boye and Zetter, 1980; Stout et al, 1993) and
downregulation of transcription and production of bFGF protein
(Singh et al, 1995a; Dinney et al, 1998) and collagenase type IV (Fabra
et al, 1992; Gohji et al, 1994; Kato et al, 1995). The chronic systemic
administration of IFN-α/β can inhibit tumor cell- and lymphocyte-
induced angiogenesis in mice (Sidky and Borden, 1987; Dvorak and
Gresser, 1989), produce regression of human bladder cancer cells in
the bladders of nude mice (Dinney et al, 1998), and accelerate the
regression of life-threatening hemangiomas of infancy (Ezekowitz et al,
1992), hemangioendotheliomas (Orchard et al, 1989), pulmonary
2Bielenberg DR, Fidler IJ, Bucana CD: Constitutive expression of interferon-
β in differentiated epithelial cells. Microscopy and Microanalysis, Cleveland, OH,
August 1997 (abstr.)
3Bielenberg D, Sanchez R, Bucana CD, et al: Critical determinants of
cutaneous angiogenesis. Proc Am Assoc Cancer Res 37:390, 1996 (abstr.)
hemangiomatosis (White et al, 1989), hemangiopericytoma (Kirn and
Kramer, 1996), and Kaposi’s sarcomas (Real et al, 1986).
How exposure to UVB radiation produces downregulation of
IFN-β expression is unclear. One possibility is that UV radiation
directly affects the IFN-β promoter through a UV response element,
as has been shown with other genes (Ronai and Weinstein, 1990;
Stein et al, 1992; Yang et al, 1993). UVB radiation has recently been
shown to downregulate the expression of IFN response factors (IRF-1
and IRF-2) that may inhibit de novo transcription of IFN-β mRNA
(Aragane et al, 1997). This mechanism may explain the 2–3 d
delay before decreased IFN-β expression was seen in the epidermis.
Alternatively, UVB radiation may induce cytokines (such as IL-10 or
transforming growth factor-β) in the epidermis or dermis that act in a
paracrine fashion to inhibit the production of IFN-β. IL-10 has
previously been shown to inhibit the expression of IFN-γ (Fiorentino
et al, 1991) but whether it can also inhibit IFN-β is still unknown.
The loss of IFN-β protein expression may be the indirect result of
hyperproliferation of epithelial cells, as suggested by recent experiments
in our laboratory that demonstrated that only differentiated or non-
dividing keratinocytes produce IFN-β (manuscript in preparation).
Regardless of the mechanism, the decrease in endogenous IFN-β
expression following UV irradiation is another immunosuppressive
effect that may account for herpes simplex virus type 1 recurrences,
which can be triggered by sunlight (Norval and el-Ghorr, 1996).
Hyperplasia and angiogenesis have an intimate relationship, as do
cells of the epidermis and dermis. Evidence suggests that the stimulus
for cutaneous neovascularization originates from epidermal, not dermal,
cells (Malhotra et al, 1989). Epithelial cells are dependent on the dermal
blood supply as their need for nutrients increases during phases of
hyperproliferation (wound healing, psoriasis, or neoplasms) (Detmar,
1996).
In conclusion, we show that exposure of mice to UVB radiation
induces epidermal hyperplasia and increased expression of positive
angiogenic molecules, but not negative (inhibitory) molecules. This
imbalance favors angiogenesis. The restoration of expression of the
negative angiogenic molecule IFN-β is associated with a return to
homeostasis. The previous finding that the administration of IFN-β
can delay wound healing (Stout et al, 1993) supports our conclusions.
This work was supported in part by Cancer Center Support Core grant CA16672 and
grant R35-CA42107 from the National Cancer Institute, National Institutes of Health.
The authors thank Donna Reynolds, Maria Shlyapobersky, and Yun Wang for their
technical support, Melissa Burkett for her expert critical review, and Lola Lo´pez for
expert preparation of this manuscript.
REFERENCES
Aragane Y, Schwarz A, Luger TA, Ariizumi K, Takashima A, Schwarz T: Ultraviolet light
suppresses IFN-gamma-induced IL-7 gene expression in murine keratinocytes by
interfering with IFN regulatory factors. J Immunol 158:5393–5399, 1997
Auerbach W, Auerbach R: Angiogenesis inhibition: a review. Pharmacol Ther 63:
265–311, 1994
Berton TR, Mitchell DL, Fischer SM, Locniskar MF: Epidermal proliferation but not
the quantity of DNA photodamage is correlated with UV-induced mouse skin
carcinogenesis. J Invest Dermatol 109:340–347, 1997
Brauchle M, Funk JO, Kind P, Werner S: Ultraviolet B and H2O2 are potent inducers of
vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem
271:21793–21797, 1996
Brouty-Boye D, Zetter BR: Inhibition of cell motility by interferon. Science 208:
516–518, 1980
Chung JH, Youn SH, Koh WS, Eun HC, Cho KH, Park KC, Youn JI: Ultraviolet B
irradiation-enhanced interleukin (IL)-6 production and mRNA expression are
mediated by IL-1α cultured human keratinocytes. J Invest Dermatol 106:715–720, 1996
Coltrera MD, Gown AM: PCNA/cyclin expression and BrdU uptake define different
subpopulations in different cell lines. J Histochem Cytochem 39:23–30, 1991
Cox NH, Diffey BL, Farr PM: The relationship between chronological age and the
erythemal response to ultraviolet B radiation. Br J Dermatol 126:315–319, 1992
Detmar M: Molecular regulation of angiogenesis in the skin. J Invest Dermatol 106:
207–208, 1996
Dinney CPN, Bielenberg D, Perrotte P, Reich R, Eve BY, Bucana CD, Fidler IJ:
Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of
human bladder carcinoma in mice by systemic interferon-alpha administration.
Cancer Res 58:808–814, 1998
872 BIELENBERG ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Donawho CK, Kripke ML: Evidence that the local effect of ultraviolet radiation on the
growth of murine melanoma is immunologically mediated. Cancer Res 51:4176–
4181, 1991
Donawho CK, Wolf P, Kripke ML: Enhanced development of murine melanoma in
UV-irradiated skin: UV dose response, wave band dependence, and relation to
inflammation. Melanoma Res 4:93–100, 1994
Dvorak HF, Gresser I: Microvascular injury in pathogenesis of interferon-induced necrosis
of subcutaneous tumors in mice. J Natl Cancer Inst 81:497–502, 1989
Enk CD, Mahanty S, Blauvelt A, Katz SI: UVB induces IL-12 transcription in human
keratinocytes in vivo and in vitro. J Photochem Photobiol 63:854–859, 1996
Ezekowitz RAB, Mulliken JB, Folkman J: Interferon alfa-2a therapy for life-threatening
hemangiomas of infancy. N Engl J Med 326:1456–1463, 1992
Fabra A, Nakajima M, Bucana CD, Fidler IJ: Modulation of the invasive phenotype of
human colon carcinoma cells by organ specific fibroblasts of nude mice. Differentiation
52:101–110, 1992
Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer
metastasis. Cell 79:185–188, 1994
Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O’Garra A:
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1
cells. J Immunol 146:3444–3451, 1991
Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med
1:27–31, 1995
Folkman J, Klagsbrun M: Angiogenic factors. Science 235:442–447, 1987
Fujimaki T, Ellis LM, Bucana CD, Radinsky R, Price JE, Fidler IJ: Simultaneous radiolabel,
genetic tagging, and proliferation assays to study the organ distribution and fate of
metastatic cells. Int J Oncol 2:895–901, 1993
Gohji K, Fidler IJ, Tsan R, Radinsky R, von Eschenbach AC, Tsuruo T, Nakajima M:
Human recombinant interferons-beta and -gamma decrease gelatinase production
and invasion by human KG-2 renal-carcinoma cells. Int J Cancer 58:380–384, 1994
Hanahan D, Christofori G, Naik P, Arbeit J: Transgenic mouse models of tumor
angiogenesis: the angiogenic switch, its molecular controls, and prospects for
preclinical therapeutic models. Eur J Cancer 32A:2386–2393, 1996
Huang S, Hendriks W, Althage A, et al: Immune response in mice that lack the interferon-
gamma receptor. Science 259:1742–1745, 1993
Iruela-Arispe ML, Dvorak HF: Angiogenesis: a dynamic balance of stimulators and
inhibitors. Thromb Haemost 78:672–677, 1997
Isaacs A, Lindenmann J: Virus interference. I. The interferon. Proc R Soc Ser B 147:
258–260, 1957
Kato N, Nawa A, Tamakoshi K, et al: Suppression of gelatinase production with decreased
invasiveness of choriocarcinoma cells by human recombinant interferon beta. Am J
Obstet Gynecol 172:601–606, 1995
Kirn DH, Kramer A: Long-term freedom from disease progression with interferon alfa
therapy in two patients with malignant hemangiopericytoma. J Natl Cancer Inst
88:764–765, 1996
Kondo S, Kono T, Sauder DN, McKenzie RC: IL-8 gene expression and production in
human keratinocytes and their modulation by UVB. J Invest Dermatol 101:
690–694, 1993
Kramer M, Sachsenmaier C, Herrlich P, Rahmsdorf HJ: UV irradiation-induced interleukin-
1 and basic fibroblast growth factor synthesis and release mediate part of the UV
response. J Biol Chem 268:6734–6741, 1993
Kripke ML: Ultraviolet radiation and immunology: something new under the sun –
presidential address. Cancer Res 54:6102–6105, 1994
Malhotra R, Stenn KS, Fernandez LA, Braverman IM: Angiogenic properties of normal
and psoriatic skin associated with epidermis, not dermis. Lab Invest 61:162–165, 1989
Marks F, Fu¨rstenberger G: Proliferative responses of the skin to external stimuli. Environ
Health Perspect 101 (Suppl. 5):95–102, 1993
Mu¨ller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkermagel RM, Aguet M:
Functional role of type I and type II interferons in antiviral defense. Science 264:
1918–1921, 1994
Naylor MF: Erythema, skin cancer risk, and sunscreens. Arch Dermatol 133:373–375, 1997
Norval M, el-Ghorr AA: UV radiation and mouse models of herpes simplex virus infection.
J Photochem Photobiol 64:242–245, 1996
Orchard PJ, Smith CM, Woods WG, Day DL, Dehner LP, Shapiro R: Treatment of
heamangioendotheliomas with alpha interferon. Lancet 2:565–567, 1989
O’Reilly MS, Holmgren L, Shing Y, et al: Angiostatin: a novel angiogenesis inhibitor that
mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:
315–328, 1994
O’Reilly MS, Boehn T, Shing Y, et al: Endostatin: an endogenous inhibitor of angiogenesis
and tumor growth. Cell 88:277–285, 1997
Pearse AD, Gaskell SA, Marks R: Epidermal changes in human skin following irradiation
with either UVB or UVA. J Invest Dermatol 88:83–87, 1987
Pfeffer LM, Dinarello CA, Herberman RB, et al: Biological properties of recombinant α-
interferons: 40th anniversary of the discovery of interferons. Cancer Res 58:
2489–2499, 1998
Real FX, Oettgen HF, Krown SE: Kaposi’s sarcoma and the acquired immunodeficiency
syndrome: treatment with high and low doses of recombinant leukocyte A interferon.
J Clin Oncol 4:544–551, 1986
Rivas JM, Ullrich SE: The role of IL-4, IL-10, and TNF-α in the immune suppression
induced by ultraviolet radiation. J Leukoc Biol 56:769–775, 1994
Ronai ZA, Weinstein IB: Identification of ultraviolet-inducible proteins that bind to a
TGACAACA sequence in the polyoma virus regulatory region. Cancer Res 50:
5374–5381, 1990
Schwarz T, Luger TA: Effect of UV irradiation on epidermal cell cytokine production.
J Photochem Photobiol 4:1–13, 1989
Shi S, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues:
an enhancement method for immunohistochemical staining based on microwave
oven heating of tissue sections. J Histochem Cytochem 39:741–748, 1991
Sidky YA, Borden EC: Inhibition of angiogenesis by interferons: effects on tumor- and
lymphocyte-induced vascular responses. Cancer Res 47:5155–5161, 1987
Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ: Interferons-α and
-β downregulate the expression of basic fibroblast growth factor in human carcinomas.
Proc Natl Acad Sci USA 92:4562–4566, 1995a
Singh RK, Gutman M, Reich R, Bar-Eli M: Ultraviolet B irradiation promotes tumorigenic
and metastatic properties in primary cutaneous melanoma via induction of interleukin
8. Cancer Res 55:3669–3674, 1995b
Soffen GA, Blum HF: Quantitative measurements of changes in mouse skin following a
single dose of ultraviolet light. J Cell Compar Physiol 58:81–96, 1961
Stein B, Angel P, van Dam H, Ponta H, Herrlich P, van der Eb A, Rahmsdorf HJ:
Ultraviolet-radiation induced c-jun gene transcription: two AP-1 like binding sites
mediate the response. Photochem Photobiol 55:409–415, 1992
Stout AJ, Gresser I, Thompson WD: Inhibition of wound healing in mice by local
interferon-β injection. Int J Exp Pathol 74:79–85, 1993
Strickland I, Rhodes LE, Flanagan BF, Friedmann PS: TNF-α and IL-8 are upregulated
in the epidermis of normal human skin after UVB exposure: correlation with
neutrophil accumulation and E-selectin expression. J Invest Dermatol 108:763–
768, 1997
Veechi A, Garlanda C, Lampugnani MG, et al: Monoclonal antibodies specific for
endothelial cells of mouse blood vessels. Their application in the identification of
adult and embryonic endothelium. Eur J Cell Biol 63:247–254, 1994
White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL: Treatment of pulmonary
hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med 320:
1197–1200, 1989
Wolf HK, Dittrich KL: Detection of proliferating cell nuclear antigen in diagnostic
histopathology. J Histochem Cytochem 40:1269–1273, 1992
Yang YM, Rutberg SE, Luo FC, Spratt TE, Halaban R, Ferrone S, Ronai Z: A
transcriptional inhibitor induced in human melanoma cells upon ultraviolet
irradiation. Cell Growth Differ 4:595–602, 1993
